• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3 炎性小体,一种针对多种疾病状态的治疗靶点。

The NLRP3 inflammasome, a target for therapy in diverse disease states.

机构信息

Section of Oncology and Clinical Research, Leeds Institute of Molecular Medicine, Leeds, UK.

出版信息

Eur J Immunol. 2010 Mar;40(3):631-4. doi: 10.1002/eji.200940162.

DOI:10.1002/eji.200940162
PMID:20201018
Abstract

A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.

摘要

NLRP3 炎性小体在复发性和慢性炎症中的作用最初在一组罕见的自身炎症性疾病中被描述,这些疾病被称为冷吡啉相关周期性综合征。随后,炎性小体被认为与许多常见疾病的病理学有关,包括癌症、痛风和糖尿病。尽管存在多种病理学,但炎性小体在先天防御和肿瘤消除中的核心作用表明,在适当的情况下,有共同的治疗方法来减轻炎症。

相似文献

1
The NLRP3 inflammasome, a target for therapy in diverse disease states.NLRP3 炎性小体,一种针对多种疾病状态的治疗靶点。
Eur J Immunol. 2010 Mar;40(3):631-4. doi: 10.1002/eji.200940162.
2
Regulation of adaptive immunity by the NLRP3 inflammasome.NLRP3 炎性小体对适应性免疫的调节。
Int Immunopharmacol. 2011 May;11(5):549-54. doi: 10.1016/j.intimp.2010.11.025. Epub 2010 Nov 27.
3
Sterile inflammatory responses mediated by the NLRP3 inflammasome.NLRP3 炎性小体介导的无菌性炎症反应。
Eur J Immunol. 2010 Mar;40(3):607-11. doi: 10.1002/eji.200940207.
4
The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants.炎症小体在颗粒状疫苗佐剂免疫刺激作用中的作用。
Eur J Immunol. 2010 Mar;40(3):634-8. doi: 10.1002/eji.200940172.
5
Signaling by ROS drives inflammasome activation.ROS 通过信号转导驱动炎症小体激活。
Eur J Immunol. 2010 Mar;40(3):616-9. doi: 10.1002/eji.200940168.
6
The inflammasome, an innate immunity guardian, participates in skin urticarial reactions and contact hypersensitivity.炎症小体,一种先天免疫守护者,参与皮肤荨麻疹反应和接触性超敏反应。
Allergol Int. 2010 Jun;59(2):105-13. doi: 10.2332/allergolint.09-RAI-0160. Epub 2010 Feb 25.
7
The NLRP3 inflammasome: a sensor for metabolic danger?NLRP3 炎性体:代谢危险的传感器?
Science. 2010 Jan 15;327(5963):296-300. doi: 10.1126/science.1184003.
8
Inflammasomes: guardians of cytosolic sanctity.炎性小体:胞质稳态的守护者。
Immunol Rev. 2009 Jan;227(1):95-105. doi: 10.1111/j.1600-065X.2008.00730.x.
9
Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence.超越NLRP3炎性小体:自身炎症性疾病步入青春期
Arthritis Rheum. 2013 May;65(5):1137-47. doi: 10.1002/art.37882.
10
Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.靶向疾病中的白细胞介素-1β;NLRP3 炎性小体的作用不断扩大。
Eur J Intern Med. 2010 Jun;21(3):157-63. doi: 10.1016/j.ejim.2010.03.005. Epub 2010 Mar 30.

引用本文的文献

1
The broad impact of cell death genes on the human disease phenome.细胞死亡基因对人类疾病表型的广泛影响。
Cell Death Dis. 2024 Apr 8;15(4):251. doi: 10.1038/s41419-024-06632-7.
2
Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.天然免疫中的 Toll 样受体 (TLRs)、NOD 样受体 (NLRs) 和 RIG-I 样受体 (RLRs)。TLRs、NLRs 和 RLRs 配体作为造血疾病的免疫治疗药物。
Int J Mol Sci. 2021 Dec 13;22(24):13397. doi: 10.3390/ijms222413397.
3
Targeting innate sensing in the tumor microenvironment to improve immunotherapy.
靶向肿瘤微环境中的先天感应以改善免疫疗法。
Cell Mol Immunol. 2020 Jan;17(1):13-26. doi: 10.1038/s41423-019-0341-y. Epub 2019 Dec 16.
4
VU0155069 inhibits inflammasome activation independent of phospholipase D1 activity.VU0155069 抑制炎症小体激活,不依赖于磷脂酶 D1 活性。
Sci Rep. 2019 Oct 4;9(1):14349. doi: 10.1038/s41598-019-50806-9.
5
Differential role of the NLRP3 inflammasome in infection and tumorigenesis.NLRP3 炎性小体在感染和肿瘤发生中的差异作用。
Immunology. 2019 Apr;156(4):329-338. doi: 10.1111/imm.13046. Epub 2019 Feb 14.
6
Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.肺炎衣原体劫持宿主自调控的 IL-1β 环促进泡沫细胞形成并加速动脉粥样硬化。
Cell Metab. 2018 Sep 4;28(3):432-448.e4. doi: 10.1016/j.cmet.2018.05.027. Epub 2018 Jun 21.
7
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.OLT1177,一种β-磺酰基腈化合物,在人体中安全,可抑制 NLRP3 炎性小体并逆转炎症的代谢代价。
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1530-E1539. doi: 10.1073/pnas.1716095115. Epub 2018 Jan 29.
8
Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment.炎性小体作为癌症预防和治疗的治疗靶点。
J Cancer Prev. 2017 Jun;22(2):62-73. doi: 10.15430/JCP.2017.22.2.62. Epub 2017 Jun 30.
9
CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.CD8 + T细胞的细胞毒性通过炎性小体激活和白细胞介素-1β的产生介导皮肤病理变化。
PLoS Pathog. 2017 Feb 13;13(2):e1006196. doi: 10.1371/journal.ppat.1006196. eCollection 2017 Feb.
10
Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.NLRP3炎性小体的激活与含缬酪肽蛋白肌病相关。
Inflammation. 2017 Feb;40(1):21-41. doi: 10.1007/s10753-016-0449-5.